Accurate glomerular filtration rate assessment remains vital for managing renal health in elderly populations. However, traditional intravenous sampling methods are often cumbersome for patients with low appetite or poor venous access. Consequently, this research investigates whether DBS iohexol GFR measurement can reliably replace traditional intravenous techniques in geriatric care. Specifically, using population pharmacokinetic modeling, clinicians can now evaluate renal function with greater convenience. Additionally, this approach enhances diagnostic precision.

Clinical Advantages of DBS Iohexol GFR Measurement

Specifically, the study compared dried blood spot sampling of iohexol against intravenous sampling. Furthermore, researchers used gentamicin clearance as a model drug to validate these measurements. Therefore, they assessed how well each method functioned as a covariate in pharmacokinetic models. Accordingly, the results demonstrated that dried blood spot sampling provided significant improvements. Similarly, the findings were comparable to standard intravenous methods. Thus, the interchangeability of these methods is statistically supported. Moreover, the performance statistics were highly encouraging for clinical adoption.

For instance, compared to intravenous iohexol, the dried blood spot method showed a minimal bias. Furthermore, the P15 value reached an impressive 98%. In contrast, intravenous 99mTc-DTPA showed a lower P15 of 78.4%. Additionally, the improvements were greater when clinicians expressed GFR in mL/min rather than indexed for body surface area. Consequently, this approach benefits patients with malnutrition. Notably, the method remains robust across different age groups. Therefore, it offers a versatile solution for renal monitoring.

Practical Implications for Geriatric Nephrology

In particular, measured GFR is often superior to estimated GFR in older medical patients. This is because older individuals often have low muscle mass. Therefore, adopting less invasive techniques is essential in the clinical context. Because dried blood spot sampling simplifies logistics, it reduces patient discomfort. Notably, it maintains high accuracy for drug dosing. Consequently, this technique represents a significant advancement in geriatric diagnostics. Meanwhile, clinicians should consider its broader implementation. Ultimately, this method improves patient outcomes.

Frequently Asked Questions

How does DBS sampling compare to traditional IV methods for GFR?

DBS sampling of iohexol offers comparable accuracy to intravenous sampling, achieving a P15 of 98%. It is less invasive and more convenient for patients with difficult venous access.

Why did researchers use gentamicin in this study?

Researchers used gentamicin as a model drug because GFR primarily determines its clearance. This allowed the team to test how well different measurement methods predicted drug clearance in population models.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Houlind MB et al. Dried Blood Spot versus i.v. sampling of Iohexol and 99mTc-DTPA for GFR Measurement. Nephrol Dial Transplant. 2026 Jun 11. doi: undefined. PMID: 42275113.


2. Carrara F, Gaspari F. GFR measured by iohexol: the best choice from a laboratory perspective. J Nephrol. 2018;31(6):837-843. doi: 10.1007/s40620-018-0531-y.


3. Houlind MB et al. Dried blood spot testing versus standard i.v. sampling for GFR measurement with iohexol or 99mTc-DTPA. PubMed. 2025.